Similar articles

• Monkeys with nigrostriatal lesions effects of monoaminergic drugs.

  Goldstein M, Anagnoste B, Battista AF, Ogawa M. Goldstein M, et al. Pharmacol Ther B. 1976;2(1):97-103. doi: 10.1016/0306-039x(76)90022-2. Pharmacol Ther B. 1976. PMID: 817335 Review. No abstract available.
• Significance of central noradrenergic system on harmaline induced tremor.

  Yamazaki M, Tanaka C, Takaori S. Yamazaki M, et al. Pharmacol Biochem Behav. 1979 Mar;10(3):421-7. doi: 10.1016/0091-3057(79)90207-7. Pharmacol Biochem Behav. 1979. PMID: 450952
• Ethanol effects on harmaline-induced tremor and increase of cerebellar cyclic GMP.

  Rappaport MS, Gentry RT, Schneider DR, Dole VP. Rappaport MS, et al. Life Sci. 1984 Jan 2;34(1):49-56. doi: 10.1016/0024-3205(84)90329-1. Life Sci. 1984. PMID: 6319933
• [Control of motor activity in relation to monoaminergic mechanisms].

  Poirier LJ, Larochelle L, Bédard P, Parent A. Poirier LJ, et al. Rev Can Biol. 1972;31:Suppl:175-80. Rev Can Biol. 1972. PMID: 4403290 French. No abstract available.
• Antiparkinsonian drugs and dopaminergic neostriatal mechanisms: studies in rats with unilateral 6-hydroxydopamine (=6-OH-DA)-induced degeneration of the nigro-neostriatal DA pathway and quantitative recording of rotational behaviour.

  Fuxe K, Ungerstedt U. Fuxe K, et al. Pharmacol Ther B. 1976;2(1):41-7. doi: 10.1016/0306-039x(76)90017-9. Pharmacol Ther B. 1976. PMID: 817332 Review. No abstract available.